Ostarine/MK-2866 25mg

Ostarine, also called MK-2866 or Enobosarm, is probably the most studied compound in the SARM class. It has been through multiple rounds of early-phase research -- an unusual distinction for a research SARM -- which means there's more characterized pharmacokinetic data available for it than for most compounds in this category. That data provides useful context for preclinical research design.

The research was primarily focused on anabolic-signaling and lean-mass-preservation pathways, where activating muscle and bone AR without the broad androgenic profile of testosterone is mechanistically interesting. Ostarine's tissue selectivity profile -- more active in muscle and bone, less so in prostate and other androgen-sensitive tissues -- is what made it scientifically interesting. The studies established receptor and pharmacokinetic parameters reported in published research datasets, even if the compound was never approved as a therapeutic.

In terms of receptor biology, Ostarine produces what's considered a partial agonist pattern at the AR in some tissues -- full activation in skeletal muscle while producing a more muted response elsewhere. This is different from testosterone, which is essentially a full agonist across all AR-expressing tissues. Understanding how that selectivity is mechanistically achieved is still an active research area.

Research Applications

Ostarine is used in research on lean mass preservation, anabolic/catabolic signaling in muscle, bone mineral density, and androgen receptor pharmacology. The existence of an extensive characterized dataset makes it useful for translational studies that need to cross-reference findings across study models.

Specifications

Storage

Store in the original sealed bottle at room temperature, away from moisture and direct light. Stable under proper storage for 24+ months.

Ostarine is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.